Left Atrial Appendage (LAA) Occluders

This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots than embolize to brain.

News | July 22, 2014
July 22, 2014 — AtriCure announced it has sold more than 34,000 AtriClip left atrial appendage (LAA) exclusion system...
atrial fibrillation, LARIAT
Feature | March 24, 2014
March 24, 2014 – Doctors at the Stony Brook Heart Institute Electrophysiology Lab are using a new nonsurgical technique...
Watchman, LAA occluder, atrial fibrillation
Feature | December 12, 2013
December 12, 2013 — The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices...
laa occluders structural heart atrial fibrillation atricure atriclip exclusion
Feature | November 19, 2013
November 19, 2013 — AtriCure Inc., a developer of solutions to treat atrial fibrillation, announced the U.S. Food and...
catheters cath lab ep laa occluders baylis medical torflex transseptal sheath
News | November 11, 2013
November 11, 2013 — The U.S. Food and Drug Administration (FDA) announced a Class I recall of Baylis Medical’s TorFlex...
Blog | November 08, 2013
By Dave Fornell, DAIC editor The Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics (TCT)...
LAA occluder, Watchman

Boston Scientific's Watchman LAA occluder device is designed to prevent stroke in patients atrial fibrillation without the need for warfarin therapy.

Feature | November 08, 2013
November 8, 2013 – According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA)...
Videos | November 07, 2013
Herbert Aronow, M.D., MPH, St. Joseph Mercy Hospital, Ann Arbor, and an active member of ACC and SCAI, explains the top...
Lariat Suture Device Left Atrial Appendage Occluder Stroke Risk
News | July 15, 2013
July 15, 2013 — Shore University Medical Center is one of only a handful of hospitals in the country offering the...
FDA US device innovation

The delay in being able to bring new medical device advances to market in the United States, such as transcatheter aortic valves and left atrial appendage occluders, has raised the question of the U.S. leadership role in technology innovation.

Feature | July 03, 2013 | Anita Asgar, M.D., FSCAI
The field of interventional cardiology is one of constant change and innovation. The past 10 years have documented...
Technology | June 28, 2013
June 28, 2013 — Maquet Cardiovascular LLC announced it has acquired LAAx Inc., a privately held company that has...
Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature | May 13, 2013
May 13, 2013 — Boston Scientific reports that the four-year follow-up data from the PROTECT AF clinical trial...
Simbionix ANGIO Mentor Structural Heart Simulator Models
Technology | May 02, 2013
May 2, 2013 — Simbionix USA Corp. released various training modules for the Angio Mentor endovascular simulator. The...
Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature | March 19, 2013
March 19, 2013 — Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co-...
Feature | March 13, 2013
March 13, 2013 — St. Jude Medical Inc. announced the first patient implant in a new pivotal trial evaluating the...